A service designed to help oncologists treat smarter
LiverWise : our AI-powered service designed to improve liver cancer care
A deadly cancer, an urgent need for precision. Every 40 seconds, someone dies from liver cancer.
Despite multiple available therapies, outcomes remain poor due to diverse disease causes and the lack of reliable biomarkers.
That's where LiverWise comes in.
Biology complexity turned into actionable guiding report
BeLiver generates a unique tumor signature by profiling the tumor and its microenvironment to help assess potential treatment response.
Our AI turns these signals into a personalized report with estimated response profiles for chemotherapies, targeted therapies, and immunotherapies, supporting evidence-based decisions.
Our goal is to bring precision to liver cancer care.
Seamlessly integrated into the patient journey
We know that time is critical in cancer care.
Our service is designed to fit existing workflows: send a small fixed biopsy sample and receive a comprehensive treatment guidance report within a week, without delaying care.
By turning complexity into clarity, we aim to enable confident, personalized decisions for better outcomes.
BeLiver's services are currently under development and are not yet commercially available. They have not received regulatory clearance (CE marking under IVDR in Europe). The information on this website describes our research and development activities and does not constitute a commercial offer or medical advice.
Interested in partnering with us?
Clinicians, researchers, pharma companies: let's shape the future of precision oncology together.
Connect with us